Filing Details

Accession Number:
0001801170-25-000176
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-07-24 16:11:12
Reporting Period:
2025-07-22
Filing Date:
2025-07-24
Accepted Time:
2025-07-24 16:11:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1801170 Clover Health Investments Corp. CLOV Hospital & Medical Service Plans (6324) 981515192
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1971702 Conrad Wai C/O Clover Health Investments, Corp.
Not Applicable
Wilmington DE 19801
Ceo, Counterpart Health No Yes No No
Transaction Summary
Sold: 209,797 shares Avg. Price: $3.30 Total Value: $692,968.04
Number of Shares After Transactions: 1,403,701 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2025-07-22 118,600 $3.29 1,494,898 No 4 S Indirect By Trust.
Class A Common Stock Disposition 2025-07-23 91,197 $3.32 1,403,701 No 4 S Indirect By Trust.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust.
No 4 S Indirect By Trust.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 1,699,767 Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.37, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
  3. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.40, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.